ADMA BIOLOGICS, INC. Inventory, LIFO Reserve, Period Charge
ADMA BIOLOGICS, INC. (ADMA) reported Inventory, LIFO Reserve, Period Charge of $2.10 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-11-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InventoryLIFOReservePeriodCharge · last filed 2023-11-08
- ADMA BIOLOGICS, INC. inventory, lifo reserve, period charge for the quarter ending 2023-06-30 was $2.10M.
| Period end | Inventory, LIFO Reserve, Period Charge | Inventory, LIFO Reserve, Period Charge 3 month |
|---|---|---|
| 2023-06-30 | $2.10M 10-Q · filed 2023-11-08 | |
| 2023-06-19 | $2.10M 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |